Quince Therapeutics, Inc. (QNCX)
0.1065
0.00 (0.00%)
USD |
NASDAQ |
Mar 13, 16:00
0.101
-0.01
(-5.16%)
After-Hours: 20:00
Quince Therapeutics Shareholders Equity (Quarterly) : 1.059M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.131B |
| Ocular Therapeutix, Inc. | 654.31M |
| Gossamer Bio, Inc. | -82.33M |
| Ernexa Therapeutics, Inc. | 3.57M |
| Acurx Pharmaceuticals, Inc. | 5.269M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.90M |
| Total Liabilities (Quarterly) | 108.84M |
| Debt to Equity Ratio | 16.99 |
| Current Ratio | 1.121 |
| Net Debt Paydown Yield | -0.81% |